United States Personal Protective Equipment Market Outlook to 2033 - Gloves, Gowns, Masks, Shoe Covers and Others - Gloves,

1.1 List of Tables
1.2 List of Figures

2.1 What Is This Report About?
2.2 Personal Protective Equipment Market Segmentation
2.3 Definitions of Markets Covered in the Report

3.1 Personal Protective Equipment Market, United States, Revenue ($m), 2018-2033
3.1.1 Gloves Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 Masks Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Personal Protective Equipment Market, United States, Volume (Units), 2018-2033
3.2.1 Gloves Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 Masks Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Personal Protective Equipment Market, United States, Average Price ($), 2018-2033
3.4 Personal Protective Equipment Market, United States, Distribution Share by Revenue ($m), 2023
3.5 Personal Protective Equipment Market, United States, Company Share by Revenue ($m), 2023

4.1 Cardinal Health Inc
4.1.1 Company Overview
4.2 Owens & Minor Inc
4.2.1 Company Overview
4.3 Medline Industries LP
4.3.1 Company Overview
4.4 Molnlycke Health Care AB
4.4.1 Company Overview
4.5 Henry Schein Inc
4.5.1 Company Overview
4.6 3M Co
4.6.1 Company Overview
4.7 TIDI Products LLC
4.7.1 Company Overview
4.8 Ansell Limited
4.8.1 Company Overview

6.1 Acquisition
6.1.1 Getinge Acquires 100% Stake in Healthmark Industries for Approximately USD320 Million
6.2 Debt Offerings
6.2.1 Becton, Dickinson and Co Raises USD600 Million in Public Offering of 5.081% Notes due 2029
6.2.2 Becton Dickinson Raises USD1.09 Billion in Public Offering of 3.828% Notes due 2032
6.2.3 Cardinal Health Raises USD650 Million in Public Offering of 5.125% Notes Due 2029
6.2.4 Cardinal Health Raises USD500 Million in Public Offering of 5.45% Notes Due 2034
6.2.5 Becton, Dickinson and Company (Becton Dickinson and Co) Raises USD625 Million in Public Offering of 4.874% Notes Due 2029

7.1 Corporate Communications
7.1.1 Aug 17, 2024: Abiomed Receives Additional FDA 510(k) Clearance for Low Profile Introducer Set 14Fr
7.1.2 Aug 01, 2024: 3M Names Anurag Maheshwari as Executive Vice President and Chief Financial Officer
7.1.3 Jul 10, 2024: 3M Announces Departure of Chief Financial Officer
7.1.4 Mar 12, 2024: 3M Announces New Leadership Appointments
7.1.5 Feb 28, 2024: Bob Azelby to Join Cardinal Health Board of Directors
7.1.6 Nov 09, 2023: 3M Announces Leadership Changes
7.1.7 Nov 07, 2023: Tom Sweet Elected to 3M Board of Directors
7.2 Financial Announcements
7.2.1 Aug 14, 2024: Cardinal Health Reports Fourth Quarter and Fiscal Year 2024 Results and Raises Fiscal Year 2025 Guidance
7.2.2 Aug 02, 2024: Moog Announces Q3 2024 Results
7.2.3 Jul 26, 2024: 3M Delivers Strong Second-Quarter Results; Company Updates Full-Year 2024 Earnings Guidance
7.2.4 Jul 17, 2024: Baxter to Host Second-Quarter 2024 Financial Results Conference Call for Investors
7.2.5 Jul 15, 2024: Integra LifeSciences to Host Second Quarter 2024 Financial Results Conference Call on July 29, 2024
7.2.6 Jul 08, 2024: Henry Schein to Webcast Second Quarter 2024 Conference Call on Tuesday, August 6, 2024 at 10:00 a.m. ET
7.2.7 Apr 30, 2024: 3M First-Quarter Results Driven by Strong Operational Performance; Company Initiates Full-Year 2024 Guidance Reflecting Completion of Solventum Spin
7.2.8 Jan 04, 2024: Baxter to Host Fourth-Quarter 2023 Financial Results Conference Call for Investors
7.2.9 Nov 08, 2023: ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update
7.2.10 Nov 03, 2023: Cardinal Health Reports First Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook
7.2.11 Oct 24, 2023: 3M Reports Third Quarter 2023 Results; Company Increases Full Year Adjusted Earnings and Cash Flow Expectations
7.2.12 Sep 19, 2023: Baxter to Host Third-Quarter 2023 Financial Results Conference Call for Investors
7.3 Government and Public Interest
7.3.1 May 21, 2024: FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
7.3.2 May 21, 2024: Henry Schein to Present at Investor Conferences in June 2024
7.3.3 May 07, 2024: Baxter to Present at Bank of America 2024 Health Care Conference
7.3.4 Jan 03, 2024: Henry Schein to Present at J.P. Morgan’s Healthcare Investor Conference
7.3.5 Nov 14, 2023: BD to Present at the 6th Annual Evercore ISI HealthCONx Conference
7.3.6 Nov 07, 2023: Henry Schein to Present at Upcoming Investor Conferences in November 2023
7.3.7 Sep 06, 2023: ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference
7.4 Legal And Regulatory
7.4.1 Apr 24, 2024: Ascentage Pharma to Present Data on APG-2449 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
7.5 Other Significant Developments
7.5.1 Oct 16, 2023: Astellas to Share New Data from Enfortumab Vedotin During ESMO Congress 2023
7.6 Strategy And Business Planning
7.6.1 Jun 13, 2024: Pall Corporation opens regional hub in Singapore

8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer

Table 1: Personal Protective Equipment Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Gloves Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Masks Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 4: Personal Protective Equipment Market, United States, Volume (Units), 2018-2033
Table 5: Gloves Market, United States, Volume (Units), 2018-2033
Table 6: Masks Market, United States, Volume (Units), 2018-2033
Table 7: Personal Protective Equipment Market, United States, Average Price ($), 2018-2033
Table 8: Personal Protective Equipment Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023
Table 9: Personal Protective Equipment Market, United States, Company Share by Revenue ($m), USD Constant, 2023
Table 10: Personal Protective Equipment Market Pipeline Products
Table 11: Getinge Acquires 100% Stake in Healthmark Industries for Approximately USD320 Million
Table 12: Becton, Dickinson and Co Raises USD600 Million in Public Offering of 5.081% Notes due 2029
Table 13: Becton Dickinson Raises USD1.09 Billion in Public Offering of 3.828% Notes due 2032
Table 14: Cardinal Health Raises USD650 Million in Public Offering of 5.125% Notes Due 2029
Table 15: Cardinal Health Raises USD500 Million in Public Offering of 5.45% Notes Due 2034
Table 16: Becton, Dickinson and Company (Becton Dickinson and Co) Raises USD625 Million in Public Offering of 4.874% Notes Due 2029
Table 17: Total Number of Primary Research Participants, Hospital Supplies Market, by Country

Figure 1: Personal Protective Equipment Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Gloves Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Masks Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 4: Personal Protective Equipment Market, United States, Volume (Units), 2018-2033
Figure 5: Gloves Market, United States, Volume (Units), 2018-2033
Figure 6: Masks Market, United States, Volume (Units), 2018-2033
Figure 7: Personal Protective Equipment Market, United States, Company Share (%) 2023